Heparin and Neutrophil percentage increased - a phase IV clinical study of FDA data

Summary:

Neutrophil percentage increased is reported as a side effect among people who take Heparin (heparin sodium), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Aspirin, and have Constipation.

The phase IV clinical study analyzes which people have Neutrophil percentage increased when taking Heparin. It is created by eHealthMe based on reports of 91,860 people who have side effects when taking Heparin from the FDA, and is updated regularly.

What is Heparin?

Heparin has active ingredients of heparin sodium. It is often used in blood clots. eHealthMe is studying from 92,141 Heparin users. Check the latest studies of Heparin.

What is Neutrophil percentage increased?

Neutrophil percentage increased is found to be associated with 270 drugs and 530 conditions by eHealthMe. Check the latest studies of Neutrophil percentage increased.

On Jul, 21, 2026

91,860 people reported to have side effects when taking Heparin.
Among them, 26 people (0.03%) have Neutrophil percentage increased.

Could Heparin cause Neutrophil percentage increased?

Among these 26 people:

How long have people been on Heparin when they have Neutrophil percentage increased? *

What is the gender of people who have Neutrophil percentage increased when taking Heparin? *

female: 42.31 %
male: 57.69 %

What is the age of people who have Neutrophil percentage increased when taking Heparin? *

What are other drugs people take besides Heparin? *

What are other side effects people have besides Neutrophil percentage increased? *

White Blood Cell Count Increased: 14 people, 53.85%
Haemoglobin Decreased: 10 people, 38.46%
Thrombocytopenia (decrease of platelets in blood): 10 people, 38.46%
Lymphocyte Percentage Decreased: 7 people, 26.92%
Nausea And Vomiting: 7 people, 26.92%
Aspartate Aminotransferase Increased: 6 people, 23.08%
Fever: 6 people, 23.08%
Hypotension (abnormally low blood pressure): 6 people, 23.08%
Haematocrit Decreased: 6 people, 23.08%
Alanine Aminotransferase Increased: 6 people, 23.08%

What are the existing conditions these people have? *

Constipation: 9 people, 34.62%
Iron Deficiency Anaemia: 6 people, 23.08%
Headache (pain in head): 5 people, 19.23%
Gastritis - Chronic (long lasting inflammation of stomach): 5 people, 19.23%
Idiopathic Thrombocytopenic Purpura (Itp) (bleeding disorder in which the immune system destroys platelets, which are necessary for normal blood clotting): 5 people, 19.23%
Osteoporosis (bones weak and more likely to break): 5 people, 19.23%
Insomnia (sleeplessness): 5 people, 19.23%
High Blood Pressure: 4 people, 15.38%
Deep Venous Thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis): 4 people, 15.38%
Coronary Heart Disease (narrowing or blockage of the coronary arteries): 2 people, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Heparin and have Neutrophil percentage increased?

- Check whether Neutrophil percentage increased is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Heparin:

Heparin (92,141 reports)

Browse all side effects of Heparin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Neutrophil percentage increased:

Neutrophil percentage increased (270 drugs)

Browse all the conditions that are associated with Neutrophil percentage increased:

Neutrophil percentage increased (530 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on heparin sodium (the active ingredients of Heparin) and Heparin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.